We are monitoring the impact of COVID-19 on Precision Medicine Software Market Get in touch with us for detailed analysis Know More
Pulished Date July, 2021
ID: 11851
Share on
Share on

Global Precision Medicine Software Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Delivery Mode, Application, End User & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)- Industry Forecast (2021 to 2026)

Pulished: July, 2021
ID: 11851
Pages: 190

Global Precision Medicine Software Market Size (2021 to 2026)

The global precision medicine software market size is forecasted to grow USD 3.99 billion in 2026 from USD 2.23 billion in 2021, growing at a CAGR of 12.40% during the forecast period.

Precision medicine is a new approach to disease treatment and prevention that considers everyone's individual variability in genes, environment, and lifestyle. Many doctors are offended by the concept that precision medicine implies that their clinical practice is still not personalized enough and thus is also not good enough. The value of disruptive technologies in clinical medicine, such as computer-guided dosing, will ultimately be determined by their ability to improve cost-effective patient care. During the forecast period, precision medicine software would increase opportunities in the biological and chemical fields.

Precision medicine software focuses on making current therapies more affordable and being at the forefront of developing new types of advanced therapies as the cost of DNA synthesis decreases. All aspects of clinical care are being targeted by novel technologies dubbed "precision medicine.

MARKET DRIVERS:

Scientific and technological advancements in precision medicine are expected to drive the global precision medicine software market during the forecast period.

Healthcare is changing, and new technologies must be used to generate new data and support precision medicine (PM). Recent scientific advances and technological advancements have improved our understanding of disease pathogenesis and changed how we diagnose and treat disease, resulting in more precise, predictable, and powerful health care tailored to each patient. Computer-guided dosing is a precision medicine technique that anticipates drug doses and responses based on individual characteristics. A Precision Medicine Tool for Multiple Sclerosis Patients creates several self-tracking, self-management, and user engagement tools for chronic disease patients.

Y-O-Y growth in the prevalence of life-threatening medical conditions, such as cancer and rare diseases, is further expected to accelerate the growth rate of the global precision medicine software market.

Cancer is one of the world's leading causes of death, accounting for approximately 9.6 million deaths in 2018. Africa, Asia, Central, and South America account for more than 60% of all new cases worldwide each year. These regions account for 70% of all cancer deaths. In 2020, it will be responsible for nearly 10 million deaths. According to the Indian organization for rare diseases, over 350 million people worldwide are affected, with 30 million in the United States, 30 million in the European Union, and 70 million in India. Over 7000 rare diseases are known/reported globally.

Artificial intelligence and cloud-based solutions are being introduced in precision medicine, which is expected to favor the growth rate of the global precision medicine software market.

Artificial intelligence (AI) technologies can play a critical role in the prevention, detection, and monitoring of epidemics. Precision medicine treatments will take personalization to the next level, focusing on individual patients' genomic, environmental, and lifestyle factors. Precision medicine studies can now be carried out by small and agile research labs and researchers worldwide thanks to Big Data technologies and Cloud Computing Services.

AI-powered health care can help public health systems handle future outbreaks more efficiently and improve patient outcomes. AI, machine learning algorithms, computational biology, and digital BMs will enable the translation of new data into actionable information, allowing for earlier diagnosis and more precise treatment options.

Additionally, factors such as growing emphasis on providing companion diagnostics and biomarkers for various therapeutic areas, increasing investments in the use of software in the healthcare industry, advanced gene therapies, growing pressure to reduce healthcare costs, and increasing geriatric population are further expected to boost the global precision medicine software market during the forecast period.

MARKET RESTRAINTS:

The high deployment cost, issues with the secure storage of large volumes of sequenced data, a lack of reimbursement for precision medicine-based treatments, and a scarcity of skilled IT professionals are a few of the significant restraints to the global precision medicine software market. In addition, concerns about data privacy and the need to comply with regulatory requirements when working with patient-related data, risk of cyber-attacks, and HIPPA regulatory compliance are also considered considerable challenges to the market of precision medicine software.

Impact of COVID-19 on the global precision medicine software market:

The COVID-19 as a pandemic and countries around the world declaring states of emergency have an impact on the processing, transportation, and supply chain of synthetic biology materials.

The virus outbreak, which was declared a pandemic in March, has sparked research and global efforts to treat and contain the virus's spread. Genomic medicine, a cutting-edge field investigating diseases and treatments using biological material's genetic material, or genome, is at the heart of this foundation. For example, genomic medicine has played a critical role in recent advances in identifying the virus and developing anti-infection therapies.

The rapidly changing environment has acted as a catalyst for change, transforming the global health community's acceptance and utilization of digital health technologies such as telemedicine, triage solutions, and digital therapeutics (DTx). Communication and collaboration among regulators, companies, researchers, hospitals, and patient organizations drive digital health adoption. Genomic tools are also being used in the development of coronavirus vaccines.

Furthermore, racial differences in COVID-19 infections and deaths in the United States are due to social factors such as increased risk exposure, limited access to care, and understandable distrust of healthcare institutions.

Using the same cell-free expression methods, researchers are now developing CRISPR-based diagnostics for rapid COVID-19 identification, as well as antiviral frontline approaches to avoid COVID-19 infection.

In light of recent findings on genetic vulnerabilities to COVID-19, PM software approaches to developing future treatments could be analogous to oncology initiatives in which both the patient's genetic predisposition and the genetics of the tumor play a role.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Delivery Mode, Application, End User & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global precision medicine software market has been segmented and sub-segmented based on delivery mode, application, end-user & region.

Precision Medicine Software Market – By Delivery Mode:

  • Web & Cloud-Based
  • On-Premise

Precision Medicine Software Market – By Application:

  • Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Other Applications

Patient Access Solutions Market - By End User:

  • Healthcare Providers
  • Research Centers and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Patient Access Solutions Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

KEY MARKET PARTICIPANTS:

A few of the promising companies operating in the global precision medicine software market profiled in this report are SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Precision Medicine Software Market, By Delivery
      1. Web & Cloud Based
      2. On-Premise
      3. Market Size Estimations & Forecasts (2021-2026)
      4. Y-o-Y Growth Rate Analysis
      5. Market Attractiveness Index
    2. Precision Medicine Software Market, By Application
      1. Oncology
      2. Pharmacogenomics
      3. Rare Diseases
      4. Other Applications
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
    3. Precision Medicine Software Market, By End User
      1. Healthcare Providers
      2. Research Centers and Academic Institutes
      3. Pharmaceutical and Biotechnology Companies
      4. Other End Users
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
  7. Geographical Landscape
    1. Global Precision Medicine Software Market, by Region
    2. North America - Market Analysis (2021 to 2026)
      1. By Country
        1. USA
        2. Canada
    3. Europe                                                   
      1. By Country
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific                                             
      1. By Country
        1. China                  
        2. India
        3. Japan                  
        4. South Korea
        5. Southeast Asia
        6. Australia & NZ
        7. Rest of Asia- Pacific
    5. Latin America
      1. By Country
        1. Brazil
        2. Argentina
        3. Mexico                
        4. Rest of Latin America
    6. The Middle East and Africa
      1. By Country
        1. Middle East
        2. Africa
  8. Key Player Analysis
    1. SOPHiA GENETICS SA
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Syapse, Inc.
    3. Foundation Medicine, Inc.
    4. 2bPrecise LLC
    5. Fabric Genomics
    6. Human Longevity, Inc.
    7. Translational Software, Inc.
    8. Gene42, Inc.
    9. IBM Watson Group
    10. LifeOmic Health, LLC
    11. Sunquest Information Systems Inc.
    12. Koninklijke Philips N.V.
    13. Flatiron Health, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of delivery mode, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Precision Medicine Software Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  3. Global Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  6. Global Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  11. Global Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  16. North America Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  18. North America Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  19. North America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  24. North America Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  28. The United States Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  29. The United States Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  30. The United States Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  31. Canada Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  32. Canada Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  33. Canada Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  34. Europe Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  35. Europe Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  36. Europe On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  37. Europe Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  38. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  39. Europe Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  40. Europe Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  41. Europe Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  42. Europe Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  43. Europe Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  44. Europe Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  45. Europe Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  46. Europe Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  47. U.K. Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  48. U.K. Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  49. U.K. Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  50. Germany Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  51. Germany Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  52. Germany Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  53. France Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  54. France Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  55. France Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  56. Italy Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  57. Italy Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  58. Italy Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  59. Spain Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  60. Spain Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  61. Spain Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  62. Asia Pacific Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  63. Asia Pacific Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  64. Asia Pacific On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  65. Asia Pacific Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  66. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  67. Asia Pacific Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  68. Asia Pacific Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  69. Asia Pacific Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  70. Asia Pacific Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  71. Asia Pacific Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  72. Asia Pacific Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  73. Asia Pacific Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  74. Asia Pacific Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  75. Japan Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  76. Japan Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  77. Japan Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  78. China Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  79. China Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  80. China Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  81. India Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  82. India Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  83. India Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  84. Australia Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  85. Australia Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  86. Australia Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  87. South Korea Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  88. South Korea Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  89. South Korea Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  90. Latin America Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  91. Latin America Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  92. Latin America On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  93. Latin America Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  94. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  95. Latin America Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  96. Latin America Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  97. Latin America Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  98. Latin America Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  99. Latin America Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  100. Latin America Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  101. Latin America Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  102. Latin America Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  103. Brazil Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  104. Brazil Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  105. Brazil Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  106. Argentina Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  107. Argentina Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  108. Argentina Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  109. Mexico Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  110. Mexico Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  111. Mexico Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  112. Rest of Latin America Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  113. Rest of Latin America Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  114. Rest of Latin America Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  115. The Middle East and Africa Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  116. The Middle East and Africa Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  117. The Middle East and Africa On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  118. The Middle East and Africa Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  119. The Middle East and Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  120. The Middle East and Africa Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  121. The Middle East and Africa Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  122. The Middle East and Africa Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  123. The Middle East and Africa Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  124. The Middle East and Africa Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  125. The Middle East and Africa Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  126. The Middle East and Africa Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  127. The Middle East and Africa Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  128. Middle East Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  129. Middle East Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  130. Middle East Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  131. Africa Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  132. Africa Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  133. Africa Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4250

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample